Document Detail


[Safety of Magnesium sulfate in severe preeclampsia].
MedLine Citation:
PMID:  22811231     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Several observational studies and randomized trials have described the use of various regimens of magnesium sulfate to prevent or reduce the rate of seizures and complications in women with severe preeclampsia.
AIM: To assess the validity of a service protocol in the management of severe pre-eclampsia all specifying the benefits, complications and side effects of magnesium sulfate .
METHODS: We have performed a retrospective descriptive study over two years (2009-2010) concerning 150 patients affected with severe preeclampsia in the department "B" of gynecology and obstetrics of the "Rabta" at the Centre of Maternity and Neonatology of Tunis (third level maternity). The protocol consisted in the administration of 3 grammes of magnesium sulfate followed by intravenous dose of 1 g/hour associated with an anti-hypertensive treatment.
RESULTS: One hundred and forty patients (93%) had 2 or more criteria of severity associated. Seventy-eight (52 %) patients with severe preeclampsia have profited an anti-hypertensive treatment based on nicardipine associated with magnesium sulfate without notable secondary effects. In two cases (1.3 %) an eclampsia was noted with magnesium sulfate, 27.4 % of severe preeclampsia was noted at a term within 34 week of amenorrhea. Only one case of surdosage was noted in post partum.
CONCLUSION: The use of magnesium sulfate in practice does not appear to increase the risk of complications or major side effects in the mother and fetus.
Authors:
Monia Malek-Mellouli; Youssef Atef; Fethi Ben Amara; Maher Nasr; Neji Khaled; Mourad Bouchnack; Hayen Maghrebi; Hedi Reziga
Publication Detail:
Type:  English Abstract; Journal Article    
Journal Detail:
Title:  La Tunisie médicale     Volume:  90     ISSN:  0041-4131     ISO Abbreviation:  Tunis Med     Publication Date:  2012 Jul 
Date Detail:
Created Date:  2012-07-19     Completed Date:  2012-11-19     Revised Date:  2014-07-31    
Medline Journal Info:
Nlm Unique ID:  0413766     Medline TA:  Tunis Med     Country:  Tunisia    
Other Details:
Languages:  fre     Pagination:  552-6     Citation Subset:  IM    
Vernacular Title:
Sulfate de Magnésium au cours de la Préeclampsie Sévère : Innocuité d’utilisation ?
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Adult
Female
Humans
Magnesium Sulfate / adverse effects,  therapeutic use*
Pre-Eclampsia / drug therapy*
Pregnancy
Retrospective Studies
Severity of Illness Index
Young Adult
Chemical
Reg. No./Substance:
7487-88-9/Magnesium Sulfate

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Thrombosis and cancer: Retrospective study of 17 cases.
Next Document:  [Emotional disorders and inflammatory bowel disease].